Thousands of men with incurable prostate cancer will be offered a lifeline after an about-turn on NHS treatment.

Thousands of men in England living with advanced prostate cancer are poised to benefit from a new life-extending drug, ...

Around 55,000 new cases of prostate cancer are diagnosed in the UK every year, and super drug abiraterone will offer hope to ...

In a statement, NICE said the new guidance for Talzenna will make it an option for around 2,400 people in England and reduce ...

Abiraterone will be available in a matter of weeks and will be offered to 7,000 men a year.

ZERO Prostate Cancer (ZERO), announces the 2026 Veterans' Action Convening, a national gathering committed to strengthening ...

Cancer is still the most common cause of death for men in the US ages 60 to 79 and women ages 40 to 79. For all adults ...

When prostate cancer has spread beyond the prostate to nearby lymph nodes and other areas of the body and treatments can no longer slow or stop its growth, you are not alone. Many patients, despite ...

Prostate cancer has overtaken breast cancer to become the most common form of the disease in the UK for the first time.

A novel long-term prediction model showed promise at estimating the risk for dying of prostate cancer, an analysis published ...

Cancer survival in the U.S. has climbed to 70%, reflecting major advances in treatment, early detection and personalized care ...